Camostat Mesylate
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation (NCT05474664) | Seoul National University Hospital | 2022-10-03 |
Track Camostat Mesylate automatically
Every clearance here is in the API, with alerts when new ones post.